 | • レポートコード：GIR-107A14992 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、成長/分化係数8のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。成長/分化係数8の種類別市場規模（OSX-200、SRK-015、ACE-2494、ACE-2798、BMS-986089、その他）、用途別市場規模（ベッカー筋ジストロフィー、線維症、骨髄線維症、鎌状赤血球症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・成長/分化係数8の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Acceleron Pharma, Inc.、Atara Biotherapeutics, Inc.、Bristol-Myers Squibb Company、Eli Lilly and Company、Milo Biotechnology LLC、Pfizer Inc.、Regeneron Pharmaceuticals, Inc.、Sarepta Therapeutics, Inc.、Scholar Rock, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：OSX-200、SRK-015、ACE-2494、ACE-2798、BMS-986089、その他 ・用途別分析2016年-2026年：ベッカー筋ジストロフィー、線維症、骨髄線維症、鎌状赤血球症、その他 ・成長/分化係数8の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・成長/分化係数8のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・成長/分化係数8のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・成長/分化係数8の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・成長/分化係数8の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Growth/Differentiation Factor 8 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Growth/Differentiation Factor 8 size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Growth/Differentiation Factor 8 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Growth/Differentiation Factor 8 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
OSX-200
SRK-015
ACE-2494
ACE-2798
BMS-986089
Others
Market segment by Application, can be divided into
Becker Muscular Dystrophy
Fibrosis
Myelofibrosis
Sickle Cell Disease
Others
Market segment by players, this report covers
Acceleron Pharma, Inc.
Atara Biotherapeutics, Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Milo Biotechnology LLC
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc.
Scholar Rock, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Growth/Differentiation Factor 8 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Growth/Differentiation Factor 8, with revenue, gross margin and global market share of Growth/Differentiation Factor 8 from 2019 to 2021.
Chapter 3, the Growth/Differentiation Factor 8 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Growth/Differentiation Factor 8 market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Growth/Differentiation Factor 8 research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Growth/Differentiation Factor 8
1.2 Classification of Growth/Differentiation Factor 8 by Type
1.2.1 Overview: Global Growth/Differentiation Factor 8 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Growth/Differentiation Factor 8 Revenue Market Share by Type in 2020
1.2.3 OSX-200
1.2.4 SRK-015
1.2.5 ACE-2494
1.2.6 ACE-2798
1.2.7 BMS-986089
1.2.8 Others
1.3 Global Growth/Differentiation Factor 8 Market by Application
1.3.1 Overview: Global Growth/Differentiation Factor 8 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Becker Muscular Dystrophy
1.3.3 Fibrosis
1.3.4 Myelofibrosis
1.3.5 Sickle Cell Disease
1.3.6 Others
1.4 Global Growth/Differentiation Factor 8 Market Size & Forecast
1.5 Global Growth/Differentiation Factor 8 Market Size and Forecast by Region
1.5.1 Global Growth/Differentiation Factor 8 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Growth/Differentiation Factor 8 Market Size by Region, (2016-2021)
1.5.3 North America Growth/Differentiation Factor 8 Market Size and Prospect (2016-2026)
1.5.4 Europe Growth/Differentiation Factor 8 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Growth/Differentiation Factor 8 Market Size and Prospect (2016-2026)
1.5.6 South America Growth/Differentiation Factor 8 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Growth/Differentiation Factor 8 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Growth/Differentiation Factor 8 Market Drivers
1.6.2 Growth/Differentiation Factor 8 Market Restraints
1.6.3 Growth/Differentiation Factor 8 Trends Analysis
2 Company Profiles
2.1 Acceleron Pharma, Inc.
2.1.1 Acceleron Pharma, Inc. Details
2.1.2 Acceleron Pharma, Inc. Major Business
2.1.3 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Product and Solutions
2.1.4 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Acceleron Pharma, Inc. Recent Developments and Future Plans
2.2 Atara Biotherapeutics, Inc.
2.2.1 Atara Biotherapeutics, Inc. Details
2.2.2 Atara Biotherapeutics, Inc. Major Business
2.2.3 Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Product and Solutions
2.2.4 Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Atara Biotherapeutics, Inc. Recent Developments and Future Plans
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business
2.3.3 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Product and Solutions
2.3.4 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Growth/Differentiation Factor 8 Product and Solutions
2.4.4 Eli Lilly and Company Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eli Lilly and Company Recent Developments and Future Plans
2.5 Milo Biotechnology LLC
2.5.1 Milo Biotechnology LLC Details
2.5.2 Milo Biotechnology LLC Major Business
2.5.3 Milo Biotechnology LLC Growth/Differentiation Factor 8 Product and Solutions
2.5.4 Milo Biotechnology LLC Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Milo Biotechnology LLC Recent Developments and Future Plans
2.6 Pfizer Inc.
2.6.1 Pfizer Inc. Details
2.6.2 Pfizer Inc. Major Business
2.6.3 Pfizer Inc. Growth/Differentiation Factor 8 Product and Solutions
2.6.4 Pfizer Inc. Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pfizer Inc. Recent Developments and Future Plans
2.7 Regeneron Pharmaceuticals, Inc.
2.7.1 Regeneron Pharmaceuticals, Inc. Details
2.7.2 Regeneron Pharmaceuticals, Inc. Major Business
2.7.3 Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Product and Solutions
2.7.4 Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Regeneron Pharmaceuticals, Inc. Recent Developments and Future Plans
2.8 Sarepta Therapeutics, Inc.
2.8.1 Sarepta Therapeutics, Inc. Details
2.8.2 Sarepta Therapeutics, Inc. Major Business
2.8.3 Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Product and Solutions
2.8.4 Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sarepta Therapeutics, Inc. Recent Developments and Future Plans
2.9 Scholar Rock, Inc.
2.9.1 Scholar Rock, Inc. Details
2.9.2 Scholar Rock, Inc. Major Business
2.9.3 Scholar Rock, Inc. Growth/Differentiation Factor 8 Product and Solutions
2.9.4 Scholar Rock, Inc. Growth/Differentiation Factor 8 Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Scholar Rock, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Growth/Differentiation Factor 8 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Growth/Differentiation Factor 8 Players Market Share
3.2.2 Top 10 Growth/Differentiation Factor 8 Players Market Share
3.2.3 Market Competition Trend
3.3 Growth/Differentiation Factor 8 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Growth/Differentiation Factor 8 Revenue and Market Share by Type (2016-2021)
4.2 Global Growth/Differentiation Factor 8 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Growth/Differentiation Factor 8 Revenue Market Share by Application (2016-2021)
5.2 Growth/Differentiation Factor 8 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Growth/Differentiation Factor 8 Revenue by Type (2016-2026)
6.2 North America Growth/Differentiation Factor 8 Revenue by Application (2016-2026)
6.3 North America Growth/Differentiation Factor 8 Market Size by Country
6.3.1 North America Growth/Differentiation Factor 8 Revenue by Country (2016-2026)
6.3.2 United States Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
6.3.3 Canada Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
6.3.4 Mexico Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Growth/Differentiation Factor 8 Revenue by Type (2016-2026)
7.2 Europe Growth/Differentiation Factor 8 Revenue by Application (2016-2026)
7.3 Europe Growth/Differentiation Factor 8 Market Size by Country
7.3.1 Europe Growth/Differentiation Factor 8 Revenue by Country (2016-2026)
7.3.2 Germany Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
7.3.3 France Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
7.3.5 Russia Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
7.3.6 Italy Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Growth/Differentiation Factor 8 Revenue by Type (2016-2026)
8.2 Asia-Pacific Growth/Differentiation Factor 8 Revenue by Application (2016-2026)
8.3 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Region
8.3.1 Asia-Pacific Growth/Differentiation Factor 8 Revenue by Region (2016-2026)
8.3.2 China Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
8.3.3 Japan Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
8.3.4 South Korea Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
8.3.5 India Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
8.3.7 Australia Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Growth/Differentiation Factor 8 Revenue by Type (2016-2026)
9.2 South America Growth/Differentiation Factor 8 Revenue by Application (2016-2026)
9.3 South America Growth/Differentiation Factor 8 Market Size by Country
9.3.1 South America Growth/Differentiation Factor 8 Revenue by Country (2016-2026)
9.3.2 Brazil Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
9.3.3 Argentina Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Growth/Differentiation Factor 8 Revenue by Type (2016-2026)
10.2 Middle East & Africa Growth/Differentiation Factor 8 Revenue by Application (2016-2026)
10.3 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Country
10.3.1 Middle East & Africa Growth/Differentiation Factor 8 Revenue by Country (2016-2026)
10.3.2 Turkey Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
10.3.4 UAE Growth/Differentiation Factor 8 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Growth/Differentiation Factor 8 Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Growth/Differentiation Factor 8 Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Growth/Differentiation Factor 8 Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Growth/Differentiation Factor 8 Revenue (USD Million) by Region (2016-2021)
Table 5. Global Growth/Differentiation Factor 8 Revenue Market Share by Region (2021-2026)
Table 6. Acceleron Pharma, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Acceleron Pharma, Inc. Major Business
Table 8. Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Product and Solutions
Table 9. Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Atara Biotherapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Atara Biotherapeutics, Inc. Major Business
Table 12. Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Product and Solutions
Table 13. Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors
Table 15. Bristol-Myers Squibb Company Major Business
Table 16. Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Product and Solutions
Table 17. Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 19. Eli Lilly and Company Major Business
Table 20. Eli Lilly and Company Growth/Differentiation Factor 8 Product and Solutions
Table 21. Eli Lilly and Company Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Milo Biotechnology LLC Corporate Information, Head Office, and Major Competitors
Table 23. Milo Biotechnology LLC Major Business
Table 24. Milo Biotechnology LLC Growth/Differentiation Factor 8 Product and Solutions
Table 25. Milo Biotechnology LLC Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Inc. Major Business
Table 28. Pfizer Inc. Growth/Differentiation Factor 8 Product and Solutions
Table 29. Pfizer Inc. Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Regeneron Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Regeneron Pharmaceuticals, Inc. Major Business
Table 32. Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Product and Solutions
Table 33. Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sarepta Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Sarepta Therapeutics, Inc. Major Business
Table 36. Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Product and Solutions
Table 37. Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Scholar Rock, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Scholar Rock, Inc. Major Business
Table 40. Scholar Rock, Inc. Growth/Differentiation Factor 8 Product and Solutions
Table 41. Scholar Rock, Inc. Growth/Differentiation Factor 8 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Growth/Differentiation Factor 8 Revenue (USD Million) by Players (2019-2021)
Table 43. Global Growth/Differentiation Factor 8 Revenue Share by Players (2019-2021)
Table 44. Breakdown of Growth/Differentiation Factor 8 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Growth/Differentiation Factor 8 Players Head Office, Products and Services Provided
Table 46. Growth/Differentiation Factor 8 Mergers & Acquisitions in the Past Five Years
Table 47. Growth/Differentiation Factor 8 New Entrants and Expansion Plans
Table 48. Global Growth/Differentiation Factor 8 Revenue (USD Million) by Type (2016-2021)
Table 49. Global Growth/Differentiation Factor 8 Revenue Share by Type (2016-2021)
Table 50. Global Growth/Differentiation Factor 8 Revenue Forecast by Type (2021-2026)
Table 51. Global Growth/Differentiation Factor 8 Revenue by Application (2016-2021)
Table 52. Global Growth/Differentiation Factor 8 Revenue Forecast by Application (2021-2026)
Table 53. North America Growth/Differentiation Factor 8 Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Growth/Differentiation Factor 8 Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Growth/Differentiation Factor 8 Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Growth/Differentiation Factor 8 Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Growth/Differentiation Factor 8 Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Growth/Differentiation Factor 8 Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Growth/Differentiation Factor 8 Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Growth/Differentiation Factor 8 Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Growth/Differentiation Factor 8 Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Growth/Differentiation Factor 8 Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Growth/Differentiation Factor 8 Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Growth/Differentiation Factor 8 Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Growth/Differentiation Factor 8 Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Growth/Differentiation Factor 8 Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Growth/Differentiation Factor 8 Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Growth/Differentiation Factor 8 Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Growth/Differentiation Factor 8 Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Growth/Differentiation Factor 8 Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Growth/Differentiation Factor 8 Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Growth/Differentiation Factor 8 Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Growth/Differentiation Factor 8 Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Growth/Differentiation Factor 8 Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Growth/Differentiation Factor 8 Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Growth/Differentiation Factor 8 Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Growth/Differentiation Factor 8 Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Growth/Differentiation Factor 8 Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Growth/Differentiation Factor 8 Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Growth/Differentiation Factor 8 Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Growth/Differentiation Factor 8 Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Growth/Differentiation Factor 8 Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Growth/Differentiation Factor 8 Picture
Figure 2. Global Growth/Differentiation Factor 8 Revenue Market Share by Type in 2020
Figure 3. OSX-200
Figure 4. SRK-015
Figure 5. ACE-2494
Figure 6. ACE-2798
Figure 7. BMS-986089
Figure 8. Others
Figure 9. Growth/Differentiation Factor 8 Revenue Market Share by Application in 2020
Figure 10. Becker Muscular Dystrophy Picture
Figure 11. Fibrosis Picture
Figure 12. Myelofibrosis Picture
Figure 13. Sickle Cell Disease Picture
Figure 14. Others Picture
Figure 15. Global Growth/Differentiation Factor 8 Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global Growth/Differentiation Factor 8 Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global Growth/Differentiation Factor 8 Revenue Market Share by Region (2016-2026)
Figure 18. Global Growth/Differentiation Factor 8 Revenue Market Share by Region in 2020
Figure 19. North America Growth/Differentiation Factor 8 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe Growth/Differentiation Factor 8 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific Growth/Differentiation Factor 8 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America Growth/Differentiation Factor 8 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Middle East and Africa Growth/Differentiation Factor 8 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Growth/Differentiation Factor 8 Market Drivers
Figure 25. Growth/Differentiation Factor 8 Market Restraints
Figure 26. Growth/Differentiation Factor 8 Market Trends
Figure 27. Acceleron Pharma, Inc. Recent Developments and Future Plans
Figure 28. Atara Biotherapeutics, Inc. Recent Developments and Future Plans
Figure 29. Bristol-Myers Squibb Company Recent Developments and Future Plans
Figure 30. Eli Lilly and Company Recent Developments and Future Plans
Figure 31. Milo Biotechnology LLC Recent Developments and Future Plans
Figure 32. Pfizer Inc. Recent Developments and Future Plans
Figure 33. Regeneron Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 34. Sarepta Therapeutics, Inc. Recent Developments and Future Plans
Figure 35. Scholar Rock, Inc. Recent Developments and Future Plans
Figure 36. Global Growth/Differentiation Factor 8 Revenue Share by Players in 2020
Figure 37. Growth/Differentiation Factor 8 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Growth/Differentiation Factor 8 Revenue Market Share in 2020
Figure 39. Global Top 10 Players Growth/Differentiation Factor 8 Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Growth/Differentiation Factor 8 Revenue Share by Type in 2020
Figure 42. Global Growth/Differentiation Factor 8 Market Share Forecast by Type (2021-2026)
Figure 43. Global Growth/Differentiation Factor 8 Revenue Share by Application in 2020
Figure 44. Global Growth/Differentiation Factor 8 Market Share Forecast by Application (2021-2026)
Figure 45. North America Growth/Differentiation Factor 8 Sales Market Share by Type (2016-2026)
Figure 46. North America Growth/Differentiation Factor 8 Sales Market Share by Application (2016-2026)
Figure 47. North America Growth/Differentiation Factor 8 Revenue Market Share by Country (2016-2026)
Figure 48. United States Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Growth/Differentiation Factor 8 Sales Market Share by Type (2016-2026)
Figure 52. Europe Growth/Differentiation Factor 8 Sales Market Share by Application (2016-2026)
Figure 53. Europe Growth/Differentiation Factor 8 Revenue Market Share by Country (2016-2026)
Figure 54. Germany Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Growth/Differentiation Factor 8 Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Growth/Differentiation Factor 8 Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Growth/Differentiation Factor 8 Revenue Market Share by Region (2016-2026)
Figure 62. China Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Growth/Differentiation Factor 8 Sales Market Share by Type (2016-2026)
Figure 69. South America Growth/Differentiation Factor 8 Sales Market Share by Application (2016-2026)
Figure 70. South America Growth/Differentiation Factor 8 Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Growth/Differentiation Factor 8 Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Growth/Differentiation Factor 8 Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Growth/Differentiation Factor 8 Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Growth/Differentiation Factor 8 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の抗血友病因子・フォンウィルブランド因子複合体市場 2021：企業別、地域別、種類・用途別 The Antihemophilic Factor & von Willebrand Factor Complex market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- 世界の抗血友病因子（組換え）市場 2021：企業別、地域別、種類・用途別 The Antihemophilic Factor (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のトランスフォーミング増殖因子β2市場 2021：企業別、地域別、種類・用途別 The Transforming Growth Factor Beta 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の線維芽細胞成長因子2市場 2021：企業別、地域別、種類・用途別 The Fibroblast Growth Factor 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の腫瘍壊死因子受容体スーパーファミリーメンバー9市場 2021：企業別、地域別、種類・用途別 The Tumor Necrosis Factor Receptor Superfamily Member 9 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…